Preferences, satisfaction and compliance with antiretroviral treatment: ARPAS study (II);Preferencias, satisfacción y adherencia con el tratamiento antirretroviral: Estudio ARPAS (II)

Farmacia Hospitalaria

Volumn 31, Issue 6, 2007, Pages 340-352

  Ventura Cerdá, José Manuel ^a,b   Casado Gomez M A ^c   Escobar Rodriguez I ^a,d   Ibarra Barrueta, O ^a,e   Ortega Valin L ^a,f   Morales Gonzalez J M ^c   Cotarelo Suarez M ^g  

^a Grupo de Trabajo VIH SIDA

^b HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^c Pharmacoeconomics and Outcomes Research Iberia (PORIB)   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL DE GALDAKAO   (Spain)

^f HOSPITAL DE LEÓN   (Spain)

^g Gilead Sciences   (Spain)

Author keywords

Acquired Immunodeficiency Syndrome; Antiretroviral therapy; Health related quality of life; HIV; Outcome assessment; Patient compliance; Patient satisfaction; Preferences

Indexed keywords

ADULT; ANTIRETROVIRAL TREATMENT SATISFACTION SCALE; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DRUG DOSE REGIMEN; FEMALE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOME STUDY HIV HEALTH SURVEY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SATISFACTION; QUALITY OF LIFE; RATING SCALE; SOCIAL ASPECT; UNIVARIATE ANALYSIS;

EID: 39549087672     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(07)75406-5     Document Type: Article

References (47)

1. Escobar I, Knobel H, Polo R, Ortega L, Marín-Conde MT, Casado JL, et al. Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia al tratamiento antirretroviral en el año 2004. Farm Hosp 2004; 28(Supl. 1): 6-18.
2. Le Moing V, Chêne G, Carrieri MP, Alioum A, Brun-Vézinet F, Piroth L, et al. Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS 2002; 16: 21-9.
3. López Aldeguer J, Pulido F, Polo R, panel de expertos de GESIDA y Plan Nacional sobre el SIDA. Recomendaciones de GESIDA/plan nacional del SIDA respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (actualización enero de 2007). Enferm Infecc Microbiol Clin 2007; 25: 32-53.
4. Barfod TS, Gerstoft J, Rodkjaer L, Pedersen C, Nielsen H, Moller A, et al. Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: A cross-sectional survey. AIDS Patient Care STDS 2005; 19: 317-25.
5. Gross R, Yip B, Lo Re V, Wood E, Alexander CS, Harrigan R, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. JID 2006; 194: 1108-14.
6. Ruiz-Pérez I, Orly de Labri-Lima A, Prada-Pardal JL, Rodríguez-Baño J, Causse-Prados M, López-Ruz MA, et al. Impacto de los factores demográficos y psicosociales en la no adherencia a los fármacos antirretrovirales. Enferm Infecc Microbiol Clin 2006; 24: 373-8.
7. Escobar I, Campo M, Martín J, Fernández-Shaw C, Pulido F, Rubio R. Factors affecting patient adherence to highly active antiretroviral therapy. Ann Pharmacother 2003; 37: 775-81.
8. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health-Syst Pharm 2003; 60: 657-65.
9. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002; 288: 2868-79.
10. Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. HIV-related knowledge and adherence to HAART. AIDS Care 2003; 15: 673-9.
11. Puigventós F, Riera M, Delibes C, Peñaranda M, de la Fuente L, Boronat A. Estudios de adherencia a los fármacos antirretrovirales. Una revisión sistemática. Med Clin (Barc) 2002; 119: 130-7.
12. Ibarra O. Preferencias y satisfacción de los pacientes con el tratamiento antirretroviral. Enferm Infecc Microbiol Clin 2005; 4: 38-42.
13. Sherer RD, Fath MJ, Da Silva BA, Nicolau AM, Miller NL. The importance of potency and durability in HIV patient antiretroviral therapy preferences: A telephone survey. AIDS Patient Care STDS 2005; 19: 794-802.
14. Godin G, Cote J, Naccache H, Lambert LD, Trottier S. Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS Care 2005; 17: 493-504.
15. Bogart LM, Bird ST, Walt LC, Delahanty DL, Figler JL. Association of stereotypes about physicians to health care satisfaction, help-seeking behavior, and adherence to treatment. Soc Sci Med 2004; 58: 1049-58.
16. Ruiz-Pérez I, Olry de Labry-Lima A, López-Ruz MA, del ArcoJiménez A, Rodríguez Baño J, Causse-Prados M, et al. Estado clínico, adherencia al TARGA y calidad de vida en pacientes con infección por el VIH tratados con antirretrovirales. Enferm Infecc Microbiol Clin 2005; 23: 581-5.
17. Badía X. La satisfacción con el tratamiento. Med Clin (Barc) 2005; 125: 98-9.
18. Adamian MS, Golin CE, Shain LS, DeVellis B. Brief motivational interviewing to improve adherence to antiretroviral therapy: Development and qualitative pilot assessment of an intervention. AIDS Patient Care STDS 2004; 18: 229-38.
19. Molassiotis A, López-Nahas V, Chung WY, Lam SW. A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care 2003; 15: 125-35.
20. Ventura JM, Sanfélix G, Monte E, Fernández EM, Alós M. Satisfacción percibida por pacientes infectados por el VIH con la unidad de atención farmacéutica a pacientes externos (UFPE). Farm Hosp 2005; 29: 134-9.
21. Bungay KM. Methods to assess the humanistic outcomes of clinical pharmacy services. Pharmacotherapy 2000; 20 (10 pt. 2): 253S-8S.
22. Craig S, Crane VS, Hayman JN, Hoffman R, Hatwig CA. Developing a service excellence system for ambulatory care pharmacy services. Am J Health-Syst Pharm 2001; 58: 1597-606.
23. Woodcock A, Bradley C. Validation of the HIV treatment satisfaction questionnaire (HIVTSQ). Qual Life Res 2001; 10: 517-31.
24. Moyle G. Once-daily therapy: Less is more. International Journal of STD & AIDS 2003; 14 (Supl. 1): 1-5.
25. Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: The GEEMA Study. AIDS 2002; 16: 605-13.
26. Ventura Cerdá JM, Casado Gómez MA, Morales González JM, Ortega Valín L, Ibarra Barrueta O, Escobar Rodríguez I. Características psicométricas de la escala de satisfacción con el tratamiento antirretroviral (ESTAR): Estudio ARPAS (I). Farm Hosp 2007; 31: 331-9.
27. Badía X, Podzamczer D, López-Lavid C, García M, Grupo Español de Validación de los cuestionarios MOS-HIV y MQOL-HIV. Medicina basada en la evidencia y la validación de cuestionarios de calidad de vida: la versión española del cuestionario MOS-HIV para la evaluación de la calidad de vida en pacientes infectados por el VIH. Enferm Infecc Microbiol Clin 1999; 17 (Supl. 2): S103-13.
28. Phatak HM, Thomas J. Relationship between beliefs about medication adherence and nonadherence to prescribed chronic medications. Ann Pharmacother 2006; 40: 1737-42.
29. Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naïve to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004; 8: 141-50.
30. Trotta MP, Ammassari A, Melzi S, Zaccarelli M, Ladisa N, Sighinolfi L, et al. Treatment-related factors and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002; 31 (Supl. 3): S128-31.
31. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296-310.
32. Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002; 31 (Supl. 3): S123-7.
33. Crisp BR, Williams M, Timpson S, Ross MW. Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS Behav 2004; 8: 199-206.
34. Tesoreiro J, French T, Weiss L, Waters M, Finkelstein R, Agins B. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. J Acquir Immune Defic Syndr 2003; 33: 484-93.
35. Turner BJ. Adherence to antiretriviral therapy by human immunodeficiency virus-infected patients. JID 2002; 185 (Supl. 2): s143-51.
36. Walsh JC, Mandalia S, Gazzard BG. Response to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002; 16: 269-77.
37. Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A. Medication adherence in patients with HIV infection: A comparison of two measured methods. AIDS Read 1999; 9: 329-38.
38. Ventura-Cerdá JM, Mínguez-Gallego C, Fernández- Villalba EM, Alós-Almiñana M, Andrés-Soler J. Escala simplificada para detectar problemas de adherencia (ESPA) al tratamiento antirretroviral. Farm Hosp 2006; 30: 171-6.
39. Alcoba M, Cuevas MJ, Pérez-Simón R, Mostaza JL, Ortega L, Ortiz de Urbina J, et al. Assessment of adherence to triple antiretroviral treatment including indinavir: Role of the determination of plasma levels of indinavir. J Acquir Immune Defic Syndr 2003; 33: 253-8.
40. Codina C, Martínez M, Tuset M, Del Cacho E, Martín MT, Miró JM, et al. Comparación de tres métodos de cálculo de adherencia en pacientes con tratamiento antirretroviral. Enferm Infecc Microbiol Clin 2002; 20: 484-90.
41. Moyle G, the APPT-1Study Team. The Assessing Patients' Preferred Treatments (APPT-1) study. International Journal of STD & AIDS 2003; 14 (Supl. 1): 34-6.
42. Miller LG, Huffman HB, Weidmer BA, Hays RD. Patient preferences regarding antiretroviral therapy. Int J STD AIDS 2002; 13: 593-601.
43. Stone VE, Jordan J, Tolson J, Miller R, Pilon T. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy. J Acquir Immune Defic Syndr 2004; 36: 808-16.
44. Bertholon DR, Rossert H, Korsia S. The patient's perspective on life with antiretroviral treatment: Results of an 887-person survey. AIDS Read 1999; 9: 462-9.
45. Jordan J, Cahn P, Goebel F, Matheron S, Bradley C, Woodcock A. Abacavir compared to protease inhibitors as part of HAART regimens for treatment of HIV infection: Patient satisfaction and implications for adherence. AIDS Patient Care STDS 2005; 19: 9-18.
46. Knobel H. Calidad de vida, stisfacción, adherencia y efectividad del tratamiento antirretroviral. Enferm Infecc Microbiol Clin 2005; 23: 579-80.
47. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004; 19: 1096-103.